Sapropterin Dihydrochloride (6r-Bh4) and Maternal Phenylketonuria Two Case Studies

ICAN: Infant, Child, & Adolescent Nutrition
doi 10.1177/1941406409344097
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

A Systematic Review of BH4 (Sapropterin) for the Adjuvant Treatment of Phenylketonuria

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2012English

Longitudinal Quality of Life Analysis in a Phenylketonuria Cohort Provided Sapropterin Dihydrochloride

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2013English

Sapropterin in the Treatment of Phenylketonuria

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2010English

P433 an Interesting Case Diagnosed as Both Phenylketonuria and Maternal Phenylketonuria

2019English

Maternal Phenylketonuria

Topics in Clinical Nutrition
NutritionDietetics
1987English

Maternal Phenylketonuria

Topics in Clinical Nutrition
NutritionDietetics
1993English

Maternal Phenylketonuria

Journal of Pediatrics
Child HealthPediatricsPerinatology
1964English

Maternal Phenylketonuria

2020English

Maternal Phenylketonuria

Journal of Pediatrics
Child HealthPediatricsPerinatology
1969English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy